Three‐dimensional model of the human aromatase enzyme and density functional parameterization of the iron‐containing protoporphyrin IX for a molecular dynamics study of heme‐cysteinato cytochromes

Mammalian cytochromes P450 (CYP) are enzymes of great biological and pharmaco‐toxicological relevance. Due to their membrane‐bound nature, the structural characterization of these proteins is extremely difficult, and therefore computational techniques, such as comparative modeling, may help obtaining reliable structures of members of this family. An important feature of CYP is the presence of an iron‐containing porphyrin group at the enzyme active site. This calls for quantum chemical calculations to derive charges and parameters suitable for classical force field‐based investigations of this proteins family. In this report, we first carried out density functional theory (DFT) computations to derive suitable charges for the Fe2+‐containing heme group of P450 enzymes. Then, by means of the homology modeling technique, and taking advantage of the recently published crystal structure of the human CYP2C9, we built a new model of the human aromatase (CYP19) enzyme. Furthermore, to study the thermal stability of the new model as well as to test the suitability of the new DFT‐based heme parameters, molecular dynamics (MD) simulations were carried out on both CYP2C9 and CYP19. Finally, the last few ns of aromatase MD trajectories were investigated following the essential dynamics protocol that allowed the detection of some correlated motions among some protein domains. Proteins 2006. © 2006 Wiley‐Liss, Inc.

[1]  A. Cavalli,et al.  Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors. , 2000, Bioorganic & medicinal chemistry.

[2]  R. Brueggemeier,et al.  The final catalytic step of cytochrome p450 aromatase: a density functional theory study. , 2005, Journal of the American Chemical Society.

[3]  W. Jentzen,et al.  Conservation of the conformation of the porphyrin macrocycle in hemoproteins. , 1998, Biophysical journal.

[4]  T. Poulos,et al.  Structure of cytochrome P450eryF involved in erythromycin biosynthesis , 1995, Nature Structural Biology.

[5]  D E McRee,et al.  Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. , 2000, Journal of inorganic biochemistry.

[6]  S. Neidle,et al.  A detailed molecular model for human aromatase , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  S. Moslemi,et al.  Aromatase inhibitors: past, present and future , 2001, Molecular and Cellular Endocrinology.

[8]  A. Brodie,et al.  Aromatase inhibitors in the treatment of breast cancer , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  K. Korzekwa,et al.  Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study. , 2001, European journal of biochemistry.

[10]  W. Miller,et al.  A time-efficient, linear-space local similarity algorithm , 1991 .

[11]  Michael Dolg,et al.  Energy‐adjusted ab initio pseudopotentials for the first row transition elements , 1987 .

[12]  Ruben Abagyan,et al.  Comparative study of several algorithms for flexible ligand docking , 2003, J. Comput. Aided Mol. Des..

[13]  Kevin M. Smith,et al.  DETERMINANTS OF THE VINYL STRETCHING FREQUENCY IN PROTOPORPHYRINS. IMPLICATIONS FOR COFACTOR-PROTEIN INTERACTIONS IN HEME PROTEINS , 1995 .

[14]  P. Kollman,et al.  Atomic charges derived from semiempirical methods , 1990 .

[15]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[16]  A. Becke A New Mixing of Hartree-Fock and Local Density-Functional Theories , 1993 .

[17]  Eric F. Johnson,et al.  Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution , 2004, Journal of Biological Chemistry.

[18]  Sason Shaik,et al.  Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. , 2004, Chemical reviews.

[19]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[20]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[21]  C. Corbin,et al.  Structural determinants of aromatase cytochrome p450 inhibition in substrate recognition site-1. , 2002, Molecular endocrinology.

[22]  W. Jentzen,et al.  Heme distortions in sperm-whale carbonmonoxy myoglobin: correlations between rotational strengths and heme distortions in MD-generated structures. , 2002, Journal of the American Chemical Society.

[23]  E. Simpson,et al.  A three‐dimensional model of aromatase cytochrome P450 , 1995, Protein science : a publication of the Protein Society.

[24]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[25]  Michele Parrinello,et al.  Equilibrium Geometries and Electronic Structure of Iron−Porphyrin Complexes: A Density Functional Study , 1997 .

[26]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[27]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[28]  Zaida Luthey-Schulten,et al.  Classical force field parameters for the heme prosthetic group of cytochrome c , 2004, J. Comput. Chem..

[29]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[30]  C. Laughton,et al.  Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study. , 1996, Cancer research.

[31]  C. Laughton,et al.  Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  Gerd Folkers,et al.  Three‐dimensional model of the cyclin‐dependent kinase 1 (CDK1): Ab initio active site parameters for molecular dynamics studies of CDKS , 2001, Proteins.

[33]  Jordi Mestres,et al.  Structure conservation in cytochromes P450 , 2004, Proteins.

[34]  Chris de Graaf,et al.  Cytochrome p450 in silico: an integrative modeling approach. , 2005, Journal of medicinal chemistry.

[35]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[36]  Sean Ekins,et al.  Pharmacophore modeling of cytochromes P450. , 2002, Advanced drug delivery reviews.

[37]  AKIFUMI ODA,et al.  New AMBER force field parameters of heme iron for cytochrome P450s determined by quantum chemical calculations of simplified models , 2005, J. Comput. Chem..

[38]  Robert D. Hancock,et al.  Molecular mechanics study of the ruffling of metalloporphyrins , 1992 .

[39]  Jack R. Collins,et al.  Valproic acid metabolism by cytochrome P450 : a theoretical study of stereoelectronic modulators of product distribution , 1991 .

[40]  P. Kollman,et al.  An approach to computing electrostatic charges for molecules , 1984 .

[41]  Yi-Ping Liu,et al.  Applications of Effective Core Potentials and Density Functional Theory to the Spin States of Iron Porphyrin , 2001, J. Chem. Inf. Comput. Sci..

[42]  L. Koymans,et al.  A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 Aromatase) , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[44]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[45]  A. Cavalli,et al.  Nonsteroidal aromatase inhibitors: Recent advances , 2002, Medicinal research reviews.

[46]  J. Jackson,et al.  Safety issues surrounding the use of aromatase inhibitors in breast cancer , 2003, Expert opinion on drug safety.

[47]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[48]  John Hodgson,et al.  ADMET—turning chemicals into drugs , 2001, Nature Biotechnology.

[49]  L. Wickert,et al.  Female Pseudohermaphroditism Associated with a Novel Homozygous G-to-A (V370-to-M) Substitution in the P-450 Aromatase Gene , 1998, Journal of pediatric endocrinology & metabolism : JPEM.

[50]  Per E M Siegbahn,et al.  Mechanisms of metalloenzymes studied by quantum chemical methods , 2003, Quarterly Reviews of Biophysics.

[51]  D. Lewis,et al.  Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal Structure , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[52]  P A Kollman,et al.  Molecular dynamics characterization of the active cavity of carboxypeptidase A and some of its inhibitor adducts , 1992, Proteins.

[53]  James R. Halpert,et al.  An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Chen,et al.  Aromatase and breast cancer. , 1998, Frontiers in bioscience : a journal and virtual library.

[55]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[56]  T. Poulos,et al.  High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.

[57]  A. Howell,et al.  A Roundtable Discussion of Aromatase Inhibitors as Therapy for Breast Cancer , 2003, The breast journal.

[58]  Abhik Ghosh,et al.  A First-Principles Quantum Chemical Analysis of the Factors Controlling Ruffling Deformations of Porphyrins: Insights from the Molecular Structures and Potential Energy Surfaces of Silicon, Phosphorus, Germanium, and Arsenic Porphyrins and of a Peroxidase Compound I Model , 1999 .

[59]  M. Parrinello,et al.  Factors Influencing Ligand-Binding Properties of Heme Models: A First Principles Study of Picket-Fence and Protoheme Complexes , 1999 .

[60]  Junmei Wang,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000, J. Comput. Chem..

[61]  D E McRee,et al.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.

[62]  C. Mendelson,et al.  Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. , 1991, The Journal of biological chemistry.

[63]  Christopher A. Reed,et al.  Spin-state/stereochemical relationships in iron porphyrins: implications for the hemoproteins , 1981 .

[64]  John Mongan,et al.  Interactive essential dynamics , 2004, J. Comput. Aided Mol. Des..

[65]  T. Poulos,et al.  A site-directed mutagenesis study of human placental aromatase. , 1992, The Journal of biological chemistry.

[66]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[67]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[68]  P. Kollman,et al.  Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation , 1993 .

[69]  Michele Parrinello,et al.  The Iron−Sulfur Bond in Cytochrome c , 1999 .

[70]  J Deisenhofer,et al.  Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.

[71]  J Deisenhofer,et al.  Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. , 1994, Journal of molecular biology.

[72]  Ulf Ryde,et al.  Comparison of methods for deriving atomic charges from the electrostatic potential and moments , 1998, J. Comput. Chem..

[73]  D. Tripathy,et al.  Aromatase inhibitors: rationale and use in breast cancer. , 2005, Annual review of medicine.

[74]  W. Jentzen,et al.  Nonplanar porphyrins and their significance in proteins , 1998 .